• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名成年患者先天性因子X缺乏症的病例报告。

A case report of congenital factor X deficiency in an adult patient.

作者信息

Al-Ansari Rehab Y, Alofi Ghufran, Aljarah Nasser, Woodman Alexander

机构信息

Adult Hematology Unit, Internal Medicine Department, King Fahad Military Medical City (KFMMC), Dhahran, Kingdom of Saudi Arabia.

Internal Medicine Department, King Fahad Military Medical City (KFMMC), Dhahran, Kingdom of Saudi Arabia.

出版信息

SAGE Open Med Case Rep. 2022 Aug 3;10:2050313X221116676. doi: 10.1177/2050313X221116676. eCollection 2022.

DOI:10.1177/2050313X221116676
PMID:35958882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9358331/
Abstract

Factor X deficiency is one of the rarest coagulation disorders representing 10% of all rare bleeding diseases with a frequency of 1:1,000,000. A 39-year-old male patient with no previous medical conditions was admitted to the hospital with a left carpal ganglion for surgical excision. Routine preoperative laboratory examination revealed a high international normalized ratio of 5.4 IU (0.8-1.1) and a prothrombin time of 72.2 s (10.9-13.6), with an isolated factor X level of less than 5%. Genetic testing for congenital factor X deficiency identified a homozygous mutation c.271 > A (p.Glu91). Vitamin K supplementation did not improve his international normalized ratio or increase factor X levels; hence, surgery was delayed. The patient was re-hospitalized to remove a wisdom tooth, during which fresh frozen plasma was administered. An allergic reaction complicated this procedure in the form of a rash on the body. As a result, the tooth was removed without active bleeding. This report presents a unique factor X deficiency case with limited treatment options to improve factor X levels after failed vitamin K administration and an allergic reaction to fresh frozen plasma. A physician's observation and ongoing follow-up were the only reasonable approaches in treating the patient with mild to moderate factor X deficiency due to lack of prothrombin complex concentrates or factor X replacement at the center at the time.

摘要

因子X缺乏症是最罕见的凝血障碍之一,占所有罕见出血性疾病的10%,发病率为1:1,000,000。一名39岁、既往无病史的男性患者因左腕腱鞘囊肿入院接受手术切除。术前常规实验室检查显示国际标准化比值高达5.4 IU(0.8 - 1.1),凝血酶原时间为72.2秒(10.9 - 13.6),孤立的因子X水平低于5%。先天性因子X缺乏症的基因检测发现纯合突变c.271>A(p.Glu91)。补充维生素K并未改善其国际标准化比值或提高因子X水平;因此,手术推迟。患者再次住院拔除智齿,期间输注了新鲜冰冻血浆。该过程出现了以全身皮疹形式的过敏反应。结果,智齿在无活动性出血的情况下被拔除。本报告展示了一例独特的因子X缺乏症病例,在维生素K治疗失败且对新鲜冰冻血浆过敏后,提高因子X水平的治疗选择有限。由于当时中心缺乏凝血酶原复合物浓缩物或因子X替代物,对于轻度至中度因子X缺乏症患者,医生的观察和持续随访是唯一合理的治疗方法。

相似文献

1
A case report of congenital factor X deficiency in an adult patient.一名成年患者先天性因子X缺乏症的病例报告。
SAGE Open Med Case Rep. 2022 Aug 3;10:2050313X221116676. doi: 10.1177/2050313X221116676. eCollection 2022.
2
Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding.手术患者的凝血酶原复合物浓缩物:维生素 K 拮抗剂逆转和严重出血治疗的回顾性评估。
Crit Care. 2009;13(6):R191. doi: 10.1186/cc8186. Epub 2009 Nov 30.
3
Diagnosis, therapeutic advances, and key recommendations for the management of factor X deficiency.因子 X 缺乏症的诊断、治疗进展及治疗管理的关键建议。
Blood Rev. 2021 Nov;50:100833. doi: 10.1016/j.blre.2021.100833. Epub 2021 Apr 27.
4
Factor X and its deficiency states.
Haemophilia. 1997 Jul;3(3):159-72. doi: 10.1046/j.1365-2516.1997.00106.x.
5
Congenital bleeding disorders of the vitamin K-dependent clotting factors.维生素K依赖凝血因子的先天性出血性疾病。
Vitam Horm. 2008;78:281-374. doi: 10.1016/S0083-6729(07)00014-3.
6
Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(®)).新诊断的先天性因子VII缺乏症及重组活化因子VII(诺其®)的应用
Clin Pharmacol. 2013;5:53-8. doi: 10.2147/CPAA.S39772. Epub 2013 Mar 15.
7
Genetic analysis of a compound heterozygous patient with congenital factor X deficiency and regular replacement therapy with a prothrombin complex concentrate.先天性因子 X 缺乏症复合杂合子患者的基因分析及使用凝血酶原复合物浓缩物进行常规替代治疗。
Int J Hematol. 2020 Jan;111(1):51-56. doi: 10.1007/s12185-019-02767-y. Epub 2019 Oct 30.
8
Factor X deficiency.凝血因子X缺乏症。
Blood Rev. 2002 Jun;16(2):97-110. doi: 10.1054/blre.2002.0191.
9
Surgical treatment for a paraplegic patient induced by congenital factor X deficiency.先天性因子X缺乏所致截瘫患者的外科治疗
Int J Clin Exp Med. 2015 Aug 15;8(8):13403-7. eCollection 2015.
10
Systematic review: 3-factor versus 4-factor prothrombin complex concentrate for warfarin reversal: does it matter?系统评价:3 因子与 4 因子凝血酶原复合物浓缩物在华法林逆转中的应用:有区别吗?
Thromb Res. 2012 Dec;130(6):833-40. doi: 10.1016/j.thromres.2012.10.001. Epub 2012 Nov 6.

引用本文的文献

1
Case report: a case of AL amyloidosis with spontaneous giant retroperitoneal hematoma.病例报告:一例伴有自发性巨大腹膜后血肿的AL淀粉样变性病例。
Int J Emerg Med. 2024 Dec 27;17(1):200. doi: 10.1186/s12245-024-00801-3.

本文引用的文献

1
A Rare Cause of Acquired Factor X Deficiency in an 87-Year-Old Female.一名87岁女性获得性因子X缺乏症的罕见病因
Case Rep Hematol. 2021 Nov 17;2021:1138329. doi: 10.1155/2021/1138329. eCollection 2021.
2
Autoimmune Coagulation Factor X Deficiency as a Rare Acquired Hemorrhagic Disorder: A Literature Review.自身免疫性凝血因子 X 缺乏症作为一种罕见的获得性出血性疾病:文献综述。
Thromb Haemost. 2022 Mar;122(3):320-328. doi: 10.1055/a-1496-8527. Epub 2021 Jun 15.
3
Acquired Factor X Deficiency in Patients With Primary Light Chain Amyloidosis.原发性轻链淀粉样变性患者获得性因子X缺乏症
J Investig Med High Impact Case Rep. 2019 Jan-Dec;7:2324709619832332. doi: 10.1177/2324709619832332.
4
Acquired factor X deficiency in light-chain (AL) amyloidosis is rare and associated with advanced disease.轻链(AL)淀粉样变性中获得性因子X缺乏症罕见,且与晚期疾病相关。
Hematol Oncol Stem Cell Ther. 2019 Mar;12(1):10-14. doi: 10.1016/j.hemonc.2018.05.002. Epub 2018 Jun 28.
5
Treatment of rare factor deficiencies in 2016.2016年罕见因子缺乏症的治疗
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):663-669. doi: 10.1182/asheducation-2016.1.663.
6
Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency.一种新型高纯度X因子浓缩物在遗传性X因子缺乏症患者中的疗效、安全性及药代动力学
Haemophilia. 2016 May;22(3):419-25. doi: 10.1111/hae.12893. Epub 2016 Mar 8.
7
Inherited Factor X (Stuart-Prower Factor) deficiency and its management.遗传性因子X(斯图尔特-普劳尔因子)缺乏症及其管理。
Med J Armed Forces India. 2015 Jul;71(Suppl 1):S184-6. doi: 10.1016/j.mjafi.2014.01.007. Epub 2014 Apr 3.
8
Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors' Organization guideline on behalf of the British Committee for Standards in Haematology.罕见凝血障碍的诊断与管理指南:英国血友病中心医生组织代表英国血液学标准委员会发布的指南
Br J Haematol. 2014 Nov;167(3):304-26. doi: 10.1111/bjh.13058. Epub 2014 Aug 6.
9
Efficacy of prophylaxis and genotype-phenotype correlation in patients with severe Factor X deficiency in Iran.伊朗严重因子 X 缺乏症患者预防治疗的效果及其基因型-表型相关性。
Haemophilia. 2012 Mar;18(2):211-5. doi: 10.1111/j.1365-2516.2011.02635.x. Epub 2011 Aug 19.
10
Factor X deficiency.凝血因子X缺乏症
Semin Thromb Hemost. 2009 Jun;35(4):407-15. doi: 10.1055/s-0029-1225763. Epub 2009 Jul 13.